{"disease":{"id":"primary-non-function","name":"primary non function"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02727296","title":"Volatile Anesthetic Protection Of Renal Transplants 2","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":488,"lead_sponsor_name":"University Medical Center Groningen","has_results":false},{"nct_id":"NCT02798861","title":"Controlled Attenuation Parameter (CAP) in Liver Allografts","phase":"","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"Andres Duarte-Rojo","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}